Thomas G. Martin, MD, discusses MRD assessment in patients with multiple myeloma and how it may be able to influence therapy selection for these patients.
Thomas G. Martin, MD, discusses MRD assessment in patients with multiple myeloma and how it may be able to influence therapy selection for these patients.
Thomas G. Martin, MD, discusses promising immunotherapies in the pipeline for multiple myeloma and how they will affect the future treatment of this disease.
Thomas G. Martin, MD, discusses promising immunotherapies in the pipeline for multiple myeloma and how they will affect the future treatment of this disease.